Skip to main content

Peer Review reports

From: Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy

Original Submission
20 Feb 2024 Submitted Original manuscript
26 Mar 2024 Reviewed Reviewer Report
30 Jul 2024 Reviewed Reviewer Report
5 Aug 2024 Author responded Author comments - Ying Dong
Resubmission - Version 2
5 Aug 2024 Submitted Manuscript version 2
8 Aug 2024 Reviewed Reviewer Report
8 Aug 2024 Reviewed Reviewer Report
13 Aug 2024 Author responded Author comments - Ying Dong
Resubmission - Version 3
13 Aug 2024 Submitted Manuscript version 3
Publishing
14 Aug 2024 Editorially accepted
20 Aug 2024 Article published 10.1186/s12885-024-12810-9

You can find further information about peer review here.

Back to article page